Anaptysbio (ANAB) Cash from Operations (2016 - 2026)
Anaptysbio (ANAB) posted Cash from Operations of 25919000.0 for Q1 2026, down 126.45% on a QoQ basis from 97997000.0 in Q4 2025, and down 142.23% year-over-year from 61370502.32 in Q1 2025.
Anaptysbio (ANAB) Cash from Operations (2016 - 2026) Analysis & Trends
Anaptysbio's Cash from Operations history runs 11 years deep, the most recent figure standing at 25919000.0 for Q1 2026.
- Quarterly Cash from Operations fell 142.23% year-over-year to 25919000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4478000.0 (up 104.12% YoY) and the FY2025 annual result came in at 19697000.0, up 114.55% from the prior year.
- Cash from Operations was 25919000.0 for Q1 2026 at Anaptysbio, down from 97997000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 97997000.0 in Q4 2025 and bottomed at 66672000.0 in Q4 2024.
- A 5-year average of 19761882.35 and a median of 24568000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 351.77% — and 2025, when it jumped 246.98%.
- Anaptysbio's Cash from Operations stood at 10685000.0 in 2022, then plunged by 221.47% to 34349000.0 in 2023, then tumbled by 94.1% to 66672000.0 in 2024, then soared by 246.98% to 97997000.0 in 2025, then sank by 126.45% to 25919000.0 in 2026.
- Business Quant data shows ANAB's Cash from Operations at 25919000.0 in Q1 2026, 97997000.0 in Q4 2025, and 27356000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - | -25.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.92 Mn |
| Mar 31, 2026 | -25.92 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Dec 31, 2025 | 98.00 Mn |
| Sep 30, 2025 | -27.36 Mn |
| Sep 30, 2025 | -27.36 Mn |
| Jun 30, 2025 | -40.24 Mn |
| Jun 30, 2025 | -40.24 Mn |
| Mar 31, 2025 | -10.70 Mn |
| Mar 31, 2025 | -10.70 Mn |
| Dec 31, 2024 | -66.67 Mn |
| Dec 31, 2024 | -66.67 Mn |
| Sep 30, 2024 | -10.09 Mn |
| Sep 30, 2024 | -10.09 Mn |
| Jun 30, 2024 | -21.32 Mn |
| Jun 30, 2024 | -21.32 Mn |
| Mar 31, 2024 | -37.25 Mn |
| Mar 31, 2024 | -37.25 Mn |
| Dec 31, 2023 | -34.35 Mn |
| Dec 31, 2023 | -34.35 Mn |